Alps Advisors Inc Acadia Pharmaceuticals Inc Transaction History

Alps Advisors Inc

  • $14.5 Billion
  • Q2 2024

A detailed history of Alps Advisors Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Alps Advisors Inc holds 128,866 shares of ACAD stock, worth $1.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128,866
Previous 116,222 10.88%
Holding current value
$1.91 Million
Previous $2.15 Million 2.51%
% of portfolio
0.01%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$14.62 - $18.42 $184,855 - $232,902
12,644 Added 10.88%
128,866 $2.09 Million
Q1 2024

May 14, 2024
BUY
$17.79 - $30.86 $79,859 - $138,530
4,489 Added 4.02%
116,222 $2.15 Million
Q4 2023

Feb 14, 2024
SELL
$20.78 - $31.77 $188,620 - $288,376
-9,077 Reduced 7.51%
111,733 $3.5 Million
Q3 2023

Nov 14, 2023
BUY
$20.84 - $33.47 $26,550 - $42,640
1,274 Added 1.07%
120,810 $2.52 Million
Q2 2023

Aug 14, 2023
BUY
$17.8 - $25.65 $225,223 - $324,549
12,653 Added 11.84%
119,536 $2.86 Million
Q1 2023

May 10, 2023
SELL
$16.32 - $20.92 $46,038 - $59,015
-2,821 Reduced 2.57%
106,883 $2.01 Million
Q4 2022

Feb 14, 2023
BUY
$14.2 - $18.63 $302,999 - $397,526
21,338 Added 24.15%
109,704 $1.75 Million
Q3 2022

Nov 14, 2022
SELL
$14.11 - $18.27 $86,324 - $111,775
-6,118 Reduced 6.48%
88,366 $1.45 Million
Q2 2022

Aug 11, 2022
SELL
$13.01 - $27.22 $926,272 - $1.94 Million
-71,197 Reduced 42.97%
94,484 $1.33 Million
Q1 2022

May 16, 2022
SELL
$20.94 - $27.5 $426,401 - $559,982
-20,363 Reduced 10.95%
165,681 $4.01 Million
Q4 2021

Feb 09, 2022
SELL
$16.79 - $27.09 $182,171 - $293,926
-10,850 Reduced 5.51%
186,044 $4.34 Million
Q3 2021

Nov 15, 2021
SELL
$15.78 - $24.77 $209,637 - $329,069
-13,285 Reduced 6.32%
196,894 $3.27 Million
Q2 2021

Aug 11, 2021
BUY
$19.4 - $27.42 $4.08 Million - $5.76 Million
210,179 New
210,179 $5.13 Million
Q4 2019

Feb 07, 2020
SELL
$36.21 - $51.4 $7.65 Million - $10.9 Million
-211,163 Closed
0 $0
Q3 2019

Nov 04, 2019
SELL
$22.22 - $44.01 $1.99 Million - $3.94 Million
-89,587 Reduced 29.79%
211,163 $7.6 Million
Q2 2019

Aug 07, 2019
BUY
$23.32 - $28.12 $7.01 Million - $8.46 Million
300,750 New
300,750 $8.04 Million
Q4 2017

Feb 05, 2018
SELL
$26.84 - $39.14 $3.24 Million - $4.72 Million
-120,544 Closed
0 $0
Q3 2017

Nov 03, 2017
BUY
$29.49 - $38.37 $3.55 Million - $4.63 Million
120,544
120,544 $4.54 Million

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email